From October 1, 2021 to December 31, 2021, the company has repurchased 4,307,000 shares, representing 0.79% for CNY 70 million. With this, the company has completed the repurchase of 6,877,000 shares, representing 1.26% for CNY 105.09 million under the buyback announced on August 4, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.45 CNY | -3.87% | -8.25% | +0.96% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.96% | 731M | |
+43.28% | 750B | |
+34.11% | 606B | |
-6.83% | 356B | |
+18.97% | 326B | |
+6.72% | 286B | |
+18.08% | 246B | |
-3.44% | 213B | |
+11.35% | 213B | |
+1.89% | 167B |
- Stock Market
- Equities
- 300497 Stock
- News Jiangxi Fushine Pharmaceutical Co., Ltd.
- Tranche Update on Jiangxi Fushine Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on August 4, 2021.